BioNote, Inc.

377740 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩4,760.00
-0.10%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.03.
  • Comfortable interest cover: operating profit covers interest about 4.5 times.
  • Current assets comfortably cover current liabilities (current ratio 31.01).
  • Pays a dividend (yield about 3.83%).
  • Has paid a dividend in each of the last 4 years on record.

!Watch-points

  • Return on equity is on the lower side at -5.8%.
  • Return on capital employed is on the lower side at 1.1%.
  • The company reported a net loss in the latest period.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.62

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩4,796억
Current Price₩ 4,760.00
High / Low₩ 6,300.00 / 4,050.00
Stock P/E-5.50
Book Value₩ 15,047.11
Dividend Yield3.83%
ROCE1.08%
ROE-5.79%
Debt to Equity0.03
Current Ratio31.01
EPS₩ -865.00
PAT Margin-73.95%
ICR4.45
Educational data only. Not a recommendation to buy, sell or hold any security.